398 related articles for article (PubMed ID: 21807911)
1. Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains.
Tennant SM; Wang JY; Galen JE; Simon R; Pasetti MF; Gat O; Levine MM
Infect Immun; 2011 Oct; 79(10):4175-85. PubMed ID: 21807911
[TBL] [Abstract][Full Text] [Related]
2. Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice.
Tennant SM; Schmidlein P; Simon R; Pasetti MF; Galen JE; Levine MM
Infect Immun; 2015 Dec; 83(12):4504-12. PubMed ID: 26351285
[TBL] [Abstract][Full Text] [Related]
3. Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis.
Simon R; Tennant SM; Wang JY; Schmidlein PJ; Lees A; Ernst RK; Pasetti MF; Galen JE; Levine MM
Infect Immun; 2011 Oct; 79(10):4240-9. PubMed ID: 21807909
[TBL] [Abstract][Full Text] [Related]
4. Mouse models for assessing the cross-protective efficacy of oral non-typhoidal Salmonella vaccine candidates harbouring in-frame deletions of the ATP-dependent protease lon and other genes.
Matsui H; Fukiya S; Kodama-Akaboshi C; Eguchi M; Yamamoto T
J Med Microbiol; 2015 Mar; 64(Pt 3):295-302. PubMed ID: 25589672
[TBL] [Abstract][Full Text] [Related]
5. Deletions in
Fuche FJ; Jones JA; Ramachandran G; Higginson EE; Simon R; Tennant SM
Hum Vaccin Immunother; 2019; 15(6):1427-1435. PubMed ID: 29927725
[TBL] [Abstract][Full Text] [Related]
6. Salmonella flagellin is not a dominant protective antigen in oral immunization with attenuated live vaccine strains.
Kodama C; Matsui H
Infect Immun; 2004 Apr; 72(4):2449-51. PubMed ID: 15039380
[TBL] [Abstract][Full Text] [Related]
7. Deletion of an immune evasion gene,
Allen JC; Natta SS; Nasrin S; Toapanta FR; Tennant SM
Front Immunol; 2024; 15():1376734. PubMed ID: 38911854
[TBL] [Abstract][Full Text] [Related]
8. Oral immunization with ATP-dependent protease-deficient mutants protects mice against subsequent oral challenge with virulent Salmonella enterica serovar typhimurium.
Matsui H; Suzuki M; Isshiki Y; Kodama C; Eguchi M; Kikuchi Y; Motokawa K; Takaya A; Tomoyasu T; Yamamoto T
Infect Immun; 2003 Jan; 71(1):30-9. PubMed ID: 12496146
[TBL] [Abstract][Full Text] [Related]
9. Protection against oral challenge three months after i.v. immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen.
Hormaeche CE; Mastroeni P; Harrison JA; Demarco de Hormaeche R; Svenson S; Stocker BA
Vaccine; 1996 Mar; 14(4):251-9. PubMed ID: 8744548
[TBL] [Abstract][Full Text] [Related]
10. Sustained protection in mice immunized with fractional doses of Salmonella Enteritidis core and O polysaccharide-flagellin glycoconjugates.
Simon R; Wang JY; Boyd MA; Tulapurkar ME; Ramachandran G; Tennant SM; Pasetti M; Galen JE; Levine MM
PLoS One; 2013; 8(5):e64680. PubMed ID: 23741368
[TBL] [Abstract][Full Text] [Related]
11. Regulated delayed synthesis of lipopolysaccharide and enterobacterial common antigen of Salmonella Typhimurium enhances immunogenicity and cross-protective efficacy against heterologous Salmonella challenge.
Huang C; Liu Q; Luo Y; Li P; Liu Q; Kong Q
Vaccine; 2016 Aug; 34(36):4285-92. PubMed ID: 27423383
[TBL] [Abstract][Full Text] [Related]
12. Salmonella Typhimurium TTSS-2 deficient mig-14 mutant shows attenuation in immunocompromised mice and offers protection against wild-type Salmonella Typhimurium infection.
Pati NB; Vishwakarma V; Selvaraj SK; Dash S; Saha B; Singh N; Suar M
BMC Microbiol; 2013 Oct; 13():236. PubMed ID: 24148706
[TBL] [Abstract][Full Text] [Related]
13. Protective Immunity Elicited by Oral Immunization of Mice with
Erova TE; Kirtley ML; Fitts EC; Ponnusamy D; Baze WB; Andersson JA; Cong Y; Tiner BL; Sha J; Chopra AK
Front Cell Infect Microbiol; 2016; 6():148. PubMed ID: 27891321
[TBL] [Abstract][Full Text] [Related]
14. SPI1 defective mutants of Salmonella enterica induce cross-protective immunity in chickens against challenge with serovars Typhimurium and Enteritidis.
Matulova M; Havlickova H; Sisak F; Babak V; Rychlik I
Vaccine; 2013 Jun; 31(31):3156-62. PubMed ID: 23684831
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and protective efficacy of a Salmonella Enteritidis sptP mutant as a live attenuated vaccine candidate.
Lin Z; Tang P; Jiao Y; Kang X; Li Q; Xu X; Sun J; Pan Z; Jiao X
BMC Vet Res; 2017 Jun; 13(1):194. PubMed ID: 28646853
[TBL] [Abstract][Full Text] [Related]
16. Improved Tolerability of a Salmonella enterica Serovar Typhimurium Live-Attenuated Vaccine Strain Achieved by Balancing Inflammatory Potential with Immunogenicity.
Higginson EE; Ramachandran G; Panda A; Shipley ST; Kriel EH; DeTolla LJ; Lipsky M; Perkins DJ; Salerno-Goncalves R; Sztein MB; Pasetti MF; Levine MM; Tennant SM
Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30249748
[TBL] [Abstract][Full Text] [Related]
17. Immunological responses induced by asd and wzy/asd mutant strains of Salmonella enterica serovar Typhimurium in BALB/c mice.
Piao HH; Tam VT; Na HS; Kim HJ; Ryu PY; Kim SY; Rhee JH; Choy HE; Kim SW; Hong Y
J Microbiol; 2010 Aug; 48(4):486-95. PubMed ID: 20799091
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Salmonella enterica serovar Typhimurium TTSS-2 deficient fur mutant as safe live-attenuated vaccine candidate for immunocompromised mice.
Vishwakarma V; Pati NB; Chandel HS; Sahoo SS; Saha B; Suar M
PLoS One; 2012; 7(12):e52043. PubMed ID: 23284865
[TBL] [Abstract][Full Text] [Related]
19. A Highly Effective Component Vaccine against Nontyphoidal Salmonella enterica Infections.
Ferreira RB; Valdez Y; Coombes BK; Sad S; Gouw JW; Brown EM; Li Y; Grassl GA; Antunes LC; Gill N; Truong M; Scholz R; Reynolds LA; Krishnan L; Zafer AA; Sal-Man N; Lowden MJ; Auweter SD; Foster LJ; Finlay BB
mBio; 2015 Sep; 6(5):e01421-15. PubMed ID: 26396246
[TBL] [Abstract][Full Text] [Related]
20. Cell-associated flagella enhance the protection conferred by mucosally-administered attenuated Salmonella Paratyphi A vaccines.
Gat O; Galen JE; Tennant S; Simon R; Blackwelder WC; Silverman DJ; Pasetti MF; Levine MM
PLoS Negl Trop Dis; 2011 Nov; 5(11):e1373. PubMed ID: 22069504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
